StaniPharm
PrivateLast Round
Seed
Jun 15, 2010
Total Funding Raised
$490,000
Company Overview
StaniPharm is a life sciences company that operates as a Contract Development and Manufacturing Organization (CDMO) providing development and GMP manufacturing services with a focus on supercritical CO2 technologies and nanomedicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StaniPharm Comparables
Compare StaniPharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Crystec Pharma | 85% | |
| CritiTech | 84% | |
| Nanoform Finland Oyj | 81% | |
StaniPharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 15, 2010 |
StaniPharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Institut Lorrain de Participation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2025
Monthly visitors increased 279% MoM.
- Oct 26, 2024
Monthly visitors increased 177% MoM.
StaniPharm Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about StaniPharm's valuation, stock price, and market status.